Multiple Myeloma & MRD

What is Multiple Myeloma?

MM is a blood cancer characterized by the clonal expansion of plasma cells in the bone marrow. Myeloma is rare, accounting for 1% of all cancers.

MM diagnosis and monitoring

Multiple myeloma diagnosis and monitoring are based on clinical symptoms and a variety of laboratory tests. M-protein detection and quantification are integral parts of diagnosis and monitoring of MM.

What is MRD ?

MRD stands for Minimal Residual Disease. It refers to the very small number of myeloma cells that are present in the bone marrow after treatment. These remaining cells often cannot be detected through traditional tests of treatment response. However, they have the potential to multiply and cause relapse.
M-inSight®
Resources
About us

Corgenix

Contracted Services to Improve Patient Outcomes

Sebia

The new language of life
Contact us
How to order?

Order M-inSight®

Multiple Myeloma & MRD
M-inSight®
Resources
About us
Contact us
How to order?
Order M-inSight®

Back
What is Multiple Myeloma?
MM diagnosis and monitoring
What is MRD ?

Back
Corgenix
Sebia

Events

11/22/2023

American Society of Hematology - ASH 2023

ASH Annual Meeting & Exposition
San Diego, CA
Sebia booth: #2455

decoration

Come & Meet us on the Sebia booth #2455

Location: San Diego, CA

See what others can't

Order M-inSight®

Multiple Myeloma & MRD

Multiple Myeloma MRD Monitoring Diagnosis and Monitoring

M-inSight®

Discover M-inSight® Ordering information Resources Contact us

© 2024 M-inSight®

Privacy Practices

Claims presented in the website are supported by references on the Resources page.